Patient


9 results

Neuroscience Patient

EACD 2020: How the use of functional assessments in clinical trials provides meaningful information for physicians treating children with cerebral palsy

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

Patient

Harnessing the power of real-world data for better, more targeted solutions for patients

By David Loew, CEO Innovation to improve patient outcomes doesn’t always resemble the scenes…

Group Patient

Fulfilling our commitment to employees and mission to patients in the context of the COVID-19 pandemic

As the COVID-19 pandemic reaches a critical stage in several countries around the world, we…

Patient

Ipsen’s first clinical trial lay summary developed with patients, for patients

Here at Ipsen, we are committed to working with patients, for patients. As part of…

Innovation Patient

#WeWontRest in using digital innovation to transform patients’ lives

September 16, 2019

[caption id="" align="aligncenter" width="262"] Harout Semerjian, EVP, Chief Commercial Officer, Ipsen[/caption] The European Federation…

Patient

COSMIC-021 trial

As part of Ipsen’s ongoing commitment to improve outcomes for patients with high unmet medical…

Patient

Standby statement on lanreotide generic

Paris (France), April 29, 2019 - Following information regarding the filing of a generic…

Neuroscience Patient

LivingWithNETs.com awarded as Most valuable patient initiative by Eyeforpharma Awards 2018*

LivingWithNETs.com is a dedicated website for patients living with neuroendocrine tumors that was designed with…

Patient

International Childhood Cancer Day, Ipsen mobilizes its teams

The premise is that all children, no matter what their background, have dreams and aspirations.…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020